Incretin-based therapy: renal effects

Incretin-based therapy: renal effects

Glucagon like peptide-1 (GLP-1) analogues and dipeptidyl peptidase-4 (DPP-4) inhibitors are new classes of hypoglycemic agents with numerous pleiotropic effects. The review summarises data about the influence of GLP-1 analogues and DPP-4 inhibitors on structural and functional changes in diabetic ki...

Full description

Bibliographic Details
Main Authors: Anton Ivanovich Korbut, Vadim Valerievich Klimontov
Format: Article
Language:English
Published: Endocrinology Research Centre 2016-01-01
Series:Сахарный диабет
Subjects:
diabetes
diabetic nephropathy
glucagon-like peptide-1
dipeptidyl peptidase-4
incretin-based therapy
Online Access:https://dia-endojournals.ru/dia/article/viewFile/7727/5621

Internet

https://dia-endojournals.ru/dia/article/viewFile/7727/5621

Similar Items